Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

Helvia. Repositorio Institucional de la Universidad de Córdoba
Publicación Artículo científico (JournalArticle)

Nox4 is involved in acute kidney injury associated to intravascular hemolysis

  • García-Caballero, Cristina
  • Guerrero-Hue, Melania
  • Vallejo-Mudarra, Mercedes
  • Palomino-Antolín, Alejandra
  • Decouty-Pérez, Celine
  • Sánchez-Mendoza, Luz Marina
  • Villalba, José Manuel
  • González Reyes, José Antonio
  • Opazo-Ríos, Lucas
  • Vázquez-Carballo, Cristina
  • Herencia, Carmen
  • Leiva-Cepas, Fernando
  • Cortegano, Isabel
  • de Andrés, Belén
  • Egido, J.
  • Egea, Javier
  • Moreno, Juan Antonio
Massive intravascular hemolysis occurs not unfrequently in many clinical conditions. Breakdown of erythrocytes promotes the accumulation of heme-derivates in the kidney, increasing oxidative stress and cell death, thus promoting acute kidney injury (AKI). NADPH oxidase 4 (Nox4) is a major source of reactive oxygen species (ROS) in the kidney, however it is unknown the role of Nox4 in hemolysis and whether inhibition of this enzyme may protect from heme-mediated injury. To answer these questions, we elicited intravascular hemolysis in wild type and Nox4 knockout mice. We also evaluated whether nephrotoxic effects of heme may be reduced by using Nox4 siRNA and pharmacologic inhibition with GKT137831, a Nox4 inhibitor, both in vivo and in cultured renal cells. Our results showed that induction of massive hemolysis elicited AKI characterized by loss of renal function, morphological alterations of the tubular epithelium and podocytes, oxidative stress, inflammation, mitochondrial dysfunction, blockade of autophagy and cell death. These pathological effects were significantly prevented in Nox4-deficient mice and in animals treated with GKT137831. In vitro studies showed that Nox4 disruption by specific siRNAs or Nox4 inhibitors declined heme-mediated ROS production and cell death. Our data identify Nox4 as a key enzyme involved in intravascular hemolysis-induced AKI. Thus, Nox4 inhibition may be a potential therapeutic approach to prevent renal damage in patients with severe hemolytic crisis.
Helvia. Repositorio Institucional de la Universidad de Córdoba
Publicación Artículo científico (JournalArticle)

Tweak/Fn14 system is involved in rhabdomyolysis-induced acute kidney injury

  • Guerrero-Hue, Melania
  • Vallejo-Mudarra, Mercedes
  • García-Caballero, Cristina
  • Córdoba-David, Gina Marcela
  • Palomino-Antolín, Alejandra
  • Herencia, Carmen
  • Vendrell-Casana, Beatriz
  • Rubio-Navarro, Alfonso
  • Egido, J.
  • Blanco-Colio, Luis M.
  • Moreno, Juan Antonio
Background Rhabdomyolysis is a severe clinical syndrome associated to acute kidney injury (AKI) and chronic kidney disease (CKD). TWEAK/Fn14 signaling axis regulates renal inflammation and tubular cell death. However, the functional role of TWEAK/Fn14 in rhabdomyolysis remains unknown. Methods Rhabdomyolysis was induced in wild-type, TWEAK- and Fn14-deficient mice or mice treated with TWEAK blocking antibody. Renal injury, inflammation, fibrosis and cell death were assessed. Additionally, we performed in vivo and in vitro studies to explore the possible signalling pathways involved in Fn14 regulation. Findings Fn14 renal expression was increased in mice with rhabdomyolysis, correlating with decline of renal function. Mechanistically, myoglobin (Mb) induced Fn14 expression via ERK and p38 pathway, whereas Nrf2 activation diminished Mb-mediated Fn14 upregulation in cultured renal cells. TWEAK or Fn14 genetic depletion ameliorated rhabdomyolysis-associated loss of renal function, histological damage, tubular cell death, inflammation, and expression of both tubular and endothelial injury markers. Deficiency of TWEAK or Fn14 also decreased long-term renal inflammation and fibrosis in mice with rhabdomyolysis. Finally, pharmacological treatment with a blocking TWEAK antibody diminished the expression of acute renal injury markers and cell death and lessened residual kidney fibrosis and chronic inflammation in rhabdomyolysis. Interpretation TWEAK/Fn14 axis participates in the pathogenesis of rhabdomyolysis-AKI and subsequent AKI-CKD transition. Blockade of this signaling pathway may represent a promising therapeutic strategy for reducing rhabdomyolysis-mediated renal injury.
Helvia. Repositorio Institucional de la Universidad de Córdoba
Publicación Artículo científico (JournalArticle)

Cytochrome b5 reductase 3 overexpression and dietary nicotinamide riboside supplementation promote distinctive mitochondrial alterations in distal convoluted tubules of mouse kidneys during aging

  • Pérez Rodríguez, Miguel
  • García-Verdugo, Alejandro
  • Sánchez-Mendoza, Luz Marina
  • Muñoz-Martín, A.
  • Bolaños, N.
  • Pérez-Sánchez, Carlos
  • Moreno, Juan Antonio
  • Burón, Isabel
  • Cabo, Rafael de
  • González Reyes, José Antonio
  • Villalba Montoro, José Manuel
The kidney undergoes structural and physiological changes with age, predominantly studied in glomeruli and proximal tubules. However, limited knowledge is available about the impact of aging and anti-aging interventions on distal tubules. In this study, we investigated the effects of cytochrome b5 reductase 3 (CYB5R3) overexpression and/or dietary nicotinamide riboside (NR) supplementation on distal tubule mitochondria. Initially, transcriptomic data were analyzed to evaluate key genes related with distal tubules, CYB5R3, and NAD+ metabolism, showing significant differences between males and females in adult and old mice. Subsequently, our emphasis focused on assessing how these interventions, that have demonstrated the anti-aging potential, influenced structural parameters of distal tubule mitochondria, such as morphology and mass, as well as abundance, distance, and length of mitochondria-endoplasmic reticulum contact sites, employing an electron microscopy approach. Our findings indicate that both interventions have differential effects depending on the age and sex of the mice. Aging resulted in an increase in mitochondrial size and a decrease in mitochondrial abundance in males, while a reduction in abundance, size, and mitochondrial mass was observed in old females when compared with their adult counterparts. Combining both the interventions, CYB5R3 overexpression and dietary NR supplementation mitigated age-related changes; however, these effects were mainly accounted by NR in males and by transgenesis in females. In conclusion, the influence of CYB5R3 overexpression and dietary NR supplementation on distal tubule mitochondria depends on sex, genotype, and diet. This underscores the importance of incorporating these variables in subsequent studies to comprehensively address the multifaceted aspects of aging.
Helvia. Repositorio Institucional de la Universidad de Córdoba
Publicación Artículo científico (JournalArticle)

Unveiling Endotypes in Systemic Lupus Erythematosus Through Multiomic Analysis: Insights Into Cardiovascular and Renal Complications

  • Cerdó, Tomás
  • Woodridge, Laurel
  • Corrales, Sagrario
  • Muñoz-Castañeda, Juan R.
  • Torralbo, Ana Isabel
  • Rahman, Anisur
  • Farinha, Filipa
  • Ortega-Castro, Rafaela
  • Segui, Pedro
  • Sánchez-Pareja, Ismael
  • Muñoz-Barrera, Laura
  • Merlo, Christian
  • Ruiz-Vilchez, Desirée
  • Ábalos-Aguilera, María del Carmen
  • Font-Ugalde, Pilar
  • Barbarroja, Nuria
  • PRECISESADS Clinical Consortium
  • Alarcón-Riquelme, Marta
  • Escudero-Contreras, Alejandro
  • Aguirre-Zamorano, M. Ángeles
  • Pérez-Sánchez, Carlos
  • Jury, Elizabeth C.
  • López-Pedrera, Chary
Objective: Systemic lupus erythematosus (SLE) shows clinical and molecular heterogeneity, and cardiovascular (CV) complications and lupus nephritis (LN) remain leading causes of morbidity and mortality. This study investigated whether omic profiling can reveal molecular endotypes linked to these outcomes. Methods: Serum from 199 patients with SLE underwent proximity extension assay–based proteomics and targeted nuclear magnetic resonance metabolomics. Unsupervised clustering was performed on proteomic data, followed by integrative multiomic factor analysis, logistic regression, and machine learning models. Cohorts with SLE from the University College London, a subset with expanded Olink Reveal panel and untargeted metabolomics, and in vitro (human umbilical vein endothelial cell and HK2) and ex vivo (rat kidneys) models exposed to patient sera were used for validation and mechanistic exploration. Results: Proteomic clustering identified two molecular subgroups (cluster 1 and cluster 2). Compared with cluster 2, cluster 1 showed damage burden and increased rates of LN (1.8-fold), hypertension (3-fold), dyslipidemia (2-fold), obesity (8-fold), and abnormal C-reactive protein/erythrocyte sedimentation rate (4-fold), consistent with CV risk. A total of 47 inflammatory and organ-damage proteins and multiple metabolites were increased in cluster 1. Neural network models based on metabolites and clinical variables discriminated clusters (area under the curve = 0.77), highlighting citrate and lipoproteins as key features. Multiomic analyses and external cohorts confirmed reproducibility and enrichment in pathways related to leukocyte trafficking, endothelial stress, and nephritis. In vitro, serum from patients with SLE induced NF-κB activation in rat kidneys compared with controls, supporting a proinflammatory effect. Conclusion: Multiomic profiling delineates molecular endotypes in SLE, integrating immune, vascular, and metabolic pathways associated with CV risk and LN, supporting their potential for precision risk stratification.
Helvia. Repositorio Institucional de la Universidad de Córdoba
Publicación Artículo científico (JournalArticle)

Cytochrome b5 reductase-3 overexpression reduces renal damage associated to intravascular hemolysis

  • García-Caballero, Cristina
  • Sánchez-Mendoza, Luz Marina
  • Vallejo-Mudarra, Mercedes
  • Beltrán-Camacho, Lucía
  • Pozuelo, Isabel
  • Valentín-Aragón, Leo
  • García-Sáez, Raquel María
  • Pérez Rodríguez, Miguel
  • Leiva-Cepas, Fernando
  • González Reyes, José Antonio
  • Más, Sebastián
  • Egido, J.
  • De Cabo, Rafael
  • Villalba, José Manuel
  • Moreno, Juan Antonio
Intravascular hemolysis can cause both acute kidney injury (AKI) and chronic kidney disease (CKD). When erythrocytes break down in the bloodstream, they release hemoglobin and heme derivatives, which accumulate in renal cells and lead to increased oxidative stress, inflammation, cell death, and mitochondrial dysfunction. The enzyme NADH-cytochrome b5 reductase 3 (CYB5R3) plays a role in NAD+ metabolism and helps reduce oxidative stress and inflammation while enhancing mitochondrial function. In this study, we examined whether overexpressing CYB5R3 offers kidney protection against AKI caused by intravascular hemolysis and prevents the progression from AKI to CKD, including analysis of sex-based differences. We created an experimental model to assess acute and chronic kidney damage related to intravascular hemolysis in wild-type (WT) and CYB5R3-overexpressing transgenic (TG) mice. Additionally, we performed in vitro experiments to determine if pharmacological induction of CYB5R3 with tetrahydroindenoindole (THII) reduced heme-mediated nephrotoxicity. AKI resulting from intravascular hemolysis impaired kidney function, increased damage to tubular epithelium and podocytes, promoted oxidative stress and inflammation, caused mitochondrial dysfunction, altered autophagy-related markers, and cell death-effects that were more severe in males than females. CYB5R3 overexpression notably diminished these pathological changes and slowed CKD progression by decreasing inflammation and fibrosis, regardless of sex. In cellular systems, induction of CYB5R3 with THII lowered heme-induced reactive oxygen species (ROS) production, inflammation, and cell death, and restored NAD+ levels. These protective effects were eliminated by pharmacological inhibition of CYB5R3 activity. Our findings suggest that CYB5R3 could be a promising therapeutic target for preventing AKI related to intravascular hemolysis and its progression to CKD.